{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T01:21:31Z","timestamp":1768008091203,"version":"3.49.0"},"reference-count":46,"publisher":"Impact Journals, LLC","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,3,29]]},"DOI":"10.18632\/oncotarget.7347","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T13:26:15Z","timestamp":1455283575000},"page":"17230-17241","source":"Crossref","is-referenced-by-count":27,"title":["Impact of cytomegalovirus reactivation on relapse and survival in patients with acute leukemia who received allogeneic hematopoietic stem cell transplantation in first remission"],"prefix":"10.18632","volume":"7","author":[{"given":"Jae-Ho","family":"Yoon","sequence":"first","affiliation":[{"name":"Department of Hematology, Catholic Blood and Marrow Transplantation Center, Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Hematology, Catholic Blood and Marrow Transplantation Center, Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Je","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Hematology, Catholic Blood and Marrow Transplantation Center, Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Woo","family":"Jeon","sequence":"additional","affiliation":[{"name":"Department of Hematology, Catholic Blood and Marrow Transplantation Center, Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Eun","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Hematology, Catholic Blood and Marrow Transplantation Center, Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung-Sik","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Hematology, Catholic Blood and Marrow Transplantation Center, Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Gun","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki-Seong","family":"Eom","sequence":"additional","affiliation":[{"name":"Department of Hematology, Catholic Blood and Marrow Transplantation Center, Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoo-Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Hematology, Catholic Blood and Marrow Transplantation Center, Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Ki","family":"Min","sequence":"additional","affiliation":[{"name":"Department of Hematology, Catholic Blood and Marrow Transplantation Center, Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok-Goo","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Hematology, Catholic Blood and Marrow Transplantation Center, Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo-Sung","family":"Min","sequence":"additional","affiliation":[{"name":"Department of Hematology, Catholic Blood and Marrow Transplantation Center, Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Wook","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Hematology, Catholic Blood and Marrow Transplantation Center, Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,2,12]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-2141.1986.tb07551.x","article-title":"Reduced risk of recurrent leukaemia in bone marrow transplant recipients after cytomegalovirus infection","volume":"63","author":"Gahrton","year":"1986","journal-title":"Br J Haematol"},{"key":"2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bbmt.2009.06.010","article-title":"Institution affects association between CMV seronegative graft and leukemic relapse after pediatric HCT","volume":"16","author":"Zaia","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbmt.2008.10.023","article-title":"Donor and recipient CMV serostatus and outcome of pediatric allogeneic HSCT for acute leukemia in the era of CMV-preemptive therapy","volume":"15","author":"Forman","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"4","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1600-0609.2005.00625.x","article-title":"Donor cytomegalovirus seropositivity and the risk of leukemic relapse after reduced-intensity transplants","volume":"76","author":"Kircher","year":"2006","journal-title":"Eur J Haematol"},{"key":"5","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0140-6736(01)06275-4","article-title":"Survival after bone marrow transplantation from cytomegalovirus seropositive sibling donors","volume":"358","author":"Larcher","year":"2001","journal-title":"Lancet"},{"key":"6","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1182\/blood-2010-08-304121","article-title":"Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients","volume":"118","author":"Schnittger","year":"2011","journal-title":"Blood"},{"key":"7","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1182\/blood-2013-02-487074","article-title":"CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia","volume":"122","author":"Boeckh","year":"2013","journal-title":"Blood"},{"key":"8","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/bmt.2013.49","article-title":"CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML","volume":"48","author":"Barrett","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"9","doi-asserted-by":"crossref","first-page":"11137","DOI":"10.1073\/pnas.93.20.11137","article-title":"Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals","volume":"93","author":"Mocarski","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbmt.2003.08.011","article-title":"Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure","volume":"10","author":"Barrett","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"11","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbmt.2006.05.008","article-title":"Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation","volume":"12","author":"Kernan","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"12","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/bmt.2008.403","article-title":"Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT","volume":"43","author":"Moss","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"13","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1182\/blood-2009-04-214684","article-title":"The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor","volume":"114","author":"Douek","year":"2009","journal-title":"Blood"},{"key":"14","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1182\/blood-2011-10-383943","article-title":"CMV-specific cellular therapy for acute myeloid leukemia?","volume":"119","author":"Peggs","year":"2012","journal-title":"Blood"},{"key":"15","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1182\/blood-2012-10-459545","article-title":"NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs","volume":"121","author":"Trowsdale","year":"2013","journal-title":"Blood"},{"key":"16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1182\/blood-2011-08-372003","article-title":"Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?","volume":"119","author":"Moretta","year":"2012","journal-title":"Blood"},{"key":"17","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1182\/blood-2005-09-3682","article-title":"Expansion of CD94\/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts","volume":"107","author":"Lopez-Botet","year":"2006","journal-title":"Blood"},{"key":"18","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1182\/blood-2011-10-386995","article-title":"Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function","volume":"119","author":"Miller","year":"2012","journal-title":"Blood"},{"key":"19","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/leu.2012.374","article-title":"gammadeltaT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia","volume":"27","author":"Plachter","year":"2013","journal-title":"Leukemia"},{"key":"20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00277-014-2190-1","article-title":"Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemia","volume":"94","author":"Min","year":"2015","journal-title":"Ann Hematol"},{"key":"21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00007890-199707150-00020","article-title":"Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture","volume":"64","author":"Bowden","year":"1997","journal-title":"Transplantation"},{"key":"22","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3346\/jkms.2009.24.4.571","article-title":"Comparison of quantitative cytomegalovirus real-time PCR in whole blood and pp65 antigenemia assay: clinical utility of CMV real-time PCR in hematopoietic stem cell transplant recipients","volume":"24","author":"Kim","year":"2009","journal-title":"J Korean Med Sci"},{"key":"23","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1128\/JCM.40.3.746-752.2002","article-title":"Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients","volume":"40","author":"Smith","year":"2002","journal-title":"J Clin Microbiol"},{"key":"24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1128\/CMR.11.3.533","article-title":"Quantitation of cytomegalovirus: methodologic aspects and clinical applications","volume":"11","author":"Boivin","year":"1998","journal-title":"Clinical microbiology reviews"},{"key":"25","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.bmt.1705986","article-title":"Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus infection in adult hematopoietic stem cell transplant recipients","volume":"41","author":"Alessandrino","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"26","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1182\/blood-2007-03-080820","article-title":"Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of preemptively treated children and young adults receiving hematopoietic stem-cell transplantation compared with qualitative pp65 antigenemia","volume":"110","author":"Locatelli","year":"2007","journal-title":"Blood"},{"key":"27","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bbmt.2007.03.009","article-title":"Ganciclovir inhibits lymphocyte proliferation by impairing DNA synthesis","volume":"13","author":"McCarthy","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"28","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood.V83.7.1971.1971","article-title":"Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis","volume":"83","author":"Riddell","year":"1994","journal-title":"Blood"},{"key":"29","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2004-05-2058","article-title":"Imprint of human cytomegalovirus infection on the NK cell receptor repertoire","volume":"104","author":"Lopez-Botet","year":"2004","journal-title":"Blood"},{"key":"30","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.4049\/jimmunol.180.7.4550","article-title":"Human cytomegalovirus infection induces a rapid and sustained change in the expression of NK cell receptors on CD8+ T cells","volume":"180","author":"van Lier","year":"2008","journal-title":"J Immunol"},{"key":"31","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1002\/eji.200636682","article-title":"Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus","volume":"36","author":"Lopez-Botet","year":"2006","journal-title":"European journal of immunology"},{"key":"32","doi-asserted-by":"crossref","first-page":"14725","DOI":"10.1073\/pnas.1110900108","article-title":"Expansion of a unique CD57(+)NKG2Chi natural killer cell subset during acute human cytomegalovirus infection","volume":"108","author":"Lanier","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"33","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/eji.201243117","article-title":"Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction","volume":"43","author":"Lopez-Botet","year":"2013","journal-title":"European journal of immunology"},{"key":"34","first-page":"149","article-title":"Comparison of antigenemia assay and semiquantitative polymerase chain reaction test for monitoring active cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients","volume":"6","author":"Abdossamadi","year":"2008","journal-title":"Experimental and clinical transplantation: official journal of the Middle East Society for Organ Transplantation"},{"key":"35","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.bbmt.2011.10.037","article-title":"Risk factors for progression from cytomegalovirus viremia to cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation","volume":"18","author":"Min","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"36","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccr.2011.11.006","article-title":"Combined genetic inactivation of beta2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma","volume":"20","author":"Dalla-Favera","year":"2011","journal-title":"Cancer Cell"},{"key":"37","doi-asserted-by":"crossref","first-page":"984","DOI":"10.6004\/jnccn.2012.0103","article-title":"Acute myeloid leukemia","volume":"10","author":"Marcucci","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"key":"38","doi-asserted-by":"crossref","first-page":"858","DOI":"10.6004\/jnccn.2012.0089","article-title":"Acute lymphoblastic leukemia","volume":"10","author":"DeAngelo","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"key":"39","first-page":"24","article-title":"Induction chemotherapy with idarubicin plus N4-behenoyl-1-beta-D-arabinofuranosylcytosine in acute myelogenous leukemia: a newly designed induction regimen\u2014a prospective, cooperative multicenter study","volume":"33","author":"Cho","year":"1996","journal-title":"Seminars in hematology"},{"key":"40","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1200\/JCO.2000.18.3.547","article-title":"Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia","volume":"18","author":"Murphy","year":"2000","journal-title":"J Clin Oncol"},{"key":"41","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1182\/blood-2004-09-3785","article-title":"The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"105","author":"Kim","year":"2005","journal-title":"Blood"},{"key":"42","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1038\/leu.2012.164","article-title":"Impact of minimal residual disease kinetics during imatinib-based treatment on transplantation outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"26","author":"Lee","year":"2012","journal-title":"Leukemia"},{"key":"43","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s12185-010-0649-y","article-title":"Favorable outcomes of intravenous busulfan, fludarabine, and 400 cGy total body irradiation-based reduced-intensity conditioning allogeneic stem cell transplantation for acute myelogenous leukemia with old age and\/or co-morbidities","volume":"92","author":"Kim","year":"2010","journal-title":"Int J Hematol"},{"key":"44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bbmt.2014.09.029","article-title":"A Well-Tolerated Regimen of 800 cGy TBI-Fludarabine-Busulfan-ATG for Reliable Engraftment after Unmanipulated Haploidentical Peripheral Blood Stem Cell Transplantation in Adult Patients with Acute Myeloid Leukemia","volume":"21","author":"Kim","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1532\/IJH97.A30402","article-title":"Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation: a single-center experience in Korea","volume":"81","author":"Min","year":"2005","journal-title":"Int J Hematol"},{"key":"46","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of k-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Annals of Statistics"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T18:26:47Z","timestamp":1589221607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,12]]},"references-count":46,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2016,3,29]]}},"alternative-id":["7347","26883100"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.7347","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,12]]}}}